Lung disease patients get access to ‘life-changing’ drug extended
Pharma company agrees to continue providing Respreeza under compassionate programme until 2018
HSE seeks assurances on ‘life-changing’ lung disease drug
Respreeza used to treat alpha-1 - a hereditary condition that is unusually common in State
Severe lung disease patients ‘distraught’ as access to drug ends
Manufacturer to end compassionate use programme for ‘life-changing’ drug Respreeza
‘Distraught’ lung disease patients to lose drug access
Calls for Simon Harris to intervene as drug firm ends compassionate use trial of Respreeza
Price row set to end access to lung disease drug
Over 20 emphysema sufferers to see use of ‘life changing’ Respreeza finish in two weeks
Emphysema patients can stay on ‘life-changing’ drug
Over 20 sufferers are given Respreeza reprieve while talks continue on approving the treatment
One of the most common lung disorders in Ireland you’ve never heard of
Alpha-1 deficiency is a hereditary condition that has an “unusually high” prevalence here
One in 25 Irish people at risk of developing chronic obstructive pulmonary disease
Doctors urge people to avail of free national screening programme
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices